Research

Researchers with the Ohio State University Wexner Medical Center are finding out more about the link between chronic pain and opioid use disorders.

The nation’s per capita supply of methadone fell 20% from the first quarter of 2020 to the second quarter of that year, according to a new analysis.

An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.

Central sensitization may be an important underlying factor that complicates the treatment of chronic pain and opioid use disorders, researchers wrote in PAIN Reports.

This first-of-its-kind study by researchers at The Ohio State University Wexner Medical Center and College of Medicine and University of Michigan Medical School explored one potential mechanism – central sensitization – among individuals with OUD.

Survey findings raise new concern about access to reproductive health care, including abortion

What You Need To Know: Rep. Mike Turner announced details of the Mainstream Addiction and Treatment Act. It's a bill that would allow practitioners to prescribe Buprenorphine without a waiver from the Drug Enforcement Administration. Buprenorphine is a prescription drug that helps treat pain and addiction to opioids. The bill has been passed by the House of Representatives and waiting to be voted on by the Senate

Synthetic opioid use increased by almost 800% over 7 years, new research shows